title: Cytokine-induced killer cells promote antitumor immunity.
abstract: The number of immune cells, especially dendritic cells and cytotoxic tumor infiltrating lymphocytes (TIL), particularly Th1 cells, CD8 T cells, and NK cells is associated with increased survival of cancer patients. Such antitumor cellular immune responses can be greatly enhanced by adoptive transfer of activated type 1 lymphocytes. Recently, adoptive cell therapy based on infusion of ex vivo expanded TILs has achieved substantial clinical success. Cytokine-induced killer (CIK) cells are a heterogeneous population of effector CD8 T cells with diverse TCR specificities, possessing non-MHC-restricted cytolytic activities against tumor cells. Preclinical studies of CIK cells in murine tumor models demonstrate significant antitumor effects against a number of hematopoietic and solid tumors. Clinical studies have confirmed benefit and safety of CIK cell-based therapy for patients with comparable malignancies. Enhancing the potency and specificity of CIK therapy via immunological and genetic engineering approaches and identifying robust biomarkers of response will significantly improve this therapy.
authors.affiliation: Department of Tumor Biological treatment, the Third Affiliated Hospital of Soochow University, 185 Juqian Street, Changzhou, 213003, China. jjtnew@163.com
authors.forename: Jingting
authors.initials: J
authors.lastname: Jiang
authors.forename: Changping
authors.initials: C
authors.lastname: Wu
authors.forename: Binfeng
authors.initials: B
authors.lastname: Lu
mesh_terms: D000818:Animals; D014408:Biomarkers, Tumor / Q000276:immunology; D001781:Blood Component Removal; D045744:Cell Line, Tumor; D055612:Cytokine-Induced Killer Cells / Q000166:cytology* / Q000502:physiology; D016207:Cytokines / Q000378:metabolism; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D007963:Leukocytes, Mononuclear / Q000166:cytology; D016246:Lymphocytes, Tumor-Infiltrating / Q000276:immunology; D051379:Mice; D016513:Mice, SCID; D009369:Neoplasms / Q000276:immunology* / Q000628:therapy*
chemical_list: D014408:Biomarkers, Tumor; D016207:Cytokines
references.citation: Clin Transl Oncol. 2012 Feb;14(2):102-8
references.pmid: 22301398
references.citation: Science. 1986 Sep 19;233(4770):1318-21
references.pmid: 3489291
references.citation: Br J Cancer. 1999 Nov;81(6):1009-16
references.pmid: 10576658
references.citation: Clin Cancer Res. 2011 Oct 1;17(19):6287-97
references.pmid: 21844012
references.citation: Curr Opin Investig Drugs. 2010 Dec;11(12):1399-408
references.pmid: 21154122
references.citation: Cell Immunol. 2008 May-Jun;253(1-2):59-65
references.pmid: 18522858
references.citation: J Exp Med. 1955 Aug 1;102(2):157-77
references.pmid: 13242741
references.citation: Science. 2006 Mar 24;311(5768):1780-4
references.pmid: 16556847
references.citation: Curr Opin Mol Ther. 2010 Jun;12(3):340-9
references.pmid: 20521223
references.citation: Int J Hematol. 2003 Feb;77(2):175-9
references.pmid: 12627854
references.citation: Blood. 2003 Jan 15;101(2):640-8
references.pmid: 12393519
references.citation: Biol Blood Marrow Transplant. 2011 Nov;17(11):1679-87
references.pmid: 21664472
references.citation: Science. 2011 Dec 16;334(6062):1573-7
references.pmid: 22174255
references.citation: J Immunol. 1987 Apr 15;138(8):2728-33
references.pmid: 2435804
references.citation: Haematologica. 2007 Jul;92(7):952-9
references.pmid: 17606446
references.citation: J Clin Oncol. 2011 Mar 1;29(7):917-24
references.pmid: 21282551
references.citation: Clin Cancer Res. 2011 Feb 15;17(4):654-66
references.pmid: 21325294
references.citation: Eur J Cancer. 1995;31A(5):698-708
references.pmid: 7640041
references.citation: Blood. 2011 Sep 22;118(12):3301-10
references.pmid: 21821703
references.citation: Eur J Immunol. 2011 Nov;41(11):3351-60
references.pmid: 21887788
references.citation: J Clin Invest. 2013 Feb;123(2):594-9
references.pmid: 23281401
references.citation: Expert Opin Biol Ther. 2011 Jul;11(7):843-53
references.pmid: 21449821
references.citation: Int Immunol. 2008 Jul;20(7):841-8
references.pmid: 18469328
references.citation: Sci Transl Med. 2011 Aug 10;3(95):95ra73
references.pmid: 21832238
references.citation: Clin Cancer Res. 2006 Mar 15;12(6):1859-67
references.pmid: 16551871
references.citation: Br J Haematol. 2002 Jan;116(1):78-86
references.pmid: 11841399
references.citation: J Transl Med. 2012 Mar 15;10:48
references.pmid: 22420641
references.citation: Blood. 2011 Nov 3;118(18):4817-28
references.pmid: 21849486
references.citation: Nature. 1995 Nov 2;378(6552):88-91
references.pmid: 7477296
references.citation: Cancer Immunol Immunother. 1998 Dec;47(4):221-6
references.pmid: 9875675
references.citation: Immunity. 2007 Aug;27(2):281-95
references.pmid: 17723218
references.citation: Cytokine. 2000 Sep;12(9):1385-90
references.pmid: 10975999
references.citation: J Immunol. 2004 Nov 1;173(9):5425-33
references.pmid: 15494489
references.citation: J Immunol. 2005 Dec 15;175(12):7819-28
references.pmid: 16339517
references.citation: Hematol Oncol. 2009 Sep;27(3):130-9
references.pmid: 19294626
references.citation: Int Immunopharmacol. 2007 Dec 15;7(13):1802-7
references.pmid: 17996691
references.citation: Blood. 1995 Nov 1;86(9):3493-9
references.pmid: 7579455
references.citation: Anticancer Res. 2006 May-Jun;26(3B):2237-42
references.pmid: 16821594
references.citation: Blood. 2009 Jul 16;114(3):535-46
references.pmid: 19451549
references.citation: Cancer Biother Radiopharm. 2005 Apr;20(2):173-80
references.pmid: 15869451
references.citation: World J Gastroenterol. 2010 Dec 28;16(48):6155-62
references.pmid: 21182234
references.citation: J Immunol. 1994 Aug 15;153(4):1687-96
references.pmid: 7519209
references.citation: Immunology. 2010 Jul;130(3):363-73
references.pmid: 20141543
references.citation: Clin Cancer Res. 2012 Oct 1;18(19):5352-63
references.pmid: 22893632
references.citation: J Transl Med. 2011 Dec 14;9:214
references.pmid: 22168571
references.citation: J Exp Med. 1991 Jul 1;174(1):139-49
references.pmid: 1711560
references.citation: Immunol Res. 2006;36(1-3):275-82
references.pmid: 17337788
references.citation: Blood. 2001 May 15;97(10):2923-31
references.pmid: 11342413
references.citation: Nat Rev Drug Discov. 2012 Feb 03;11(3):215-33
references.pmid: 22301798
references.citation: J Immunol. 1980 Jul;125(1):238-45
references.pmid: 6966652
references.citation: Cancer Immunol Immunother. 2010 Sep;59(9):1325-34
references.pmid: 20532883
references.citation: Exp Hematol. 1995 Dec;23(14):1676-81
references.pmid: 8542964
references.citation: J Immunol. 2008 Jun 15;180(12):7898-906
references.pmid: 18523253
references.citation: J Immunother. 2012 Sep;35(7):579-86
references.pmid: 22892454
references.citation: Blood. 2012 Mar 22;119(12):2709-20
references.pmid: 22160384
references.citation: Biol Blood Marrow Transplant. 2001;7(10):532-42
references.pmid: 11760085
references.citation: Cytotherapy. 2012 Jan;14(1):91-103
references.pmid: 21973023
references.citation: Leuk Res. 2011 Sep;35(9):1136-42
references.pmid: 21652069
references.citation: Clin Cancer Res. 2011 Jul 1;17(13):4550-7
references.pmid: 21498393
references.citation: Anticancer Res. 2010 Sep;30(9):3493-9
references.pmid: 20944128
references.citation: J Immunol. 1980 Oct;125(4):1487-93
references.pmid: 6967906
references.citation: Science. 2001 Oct 19;294(5542):605-9
references.pmid: 11567106
references.citation: J Cell Biol. 2010 Sep 6;190(5):881-92
references.pmid: 20819940
references.citation: Exp Hematol. 1993 Dec;21(13):1673-9
references.pmid: 7694868
references.citation: Anticancer Res. 2008 Nov-Dec;28(6B):3997-4002
references.pmid: 19192663
references.citation: Blood. 1998 Nov 1;92(9):3318-27
references.pmid: 9787169
references.citation: Antioxid Redox Signal. 2011 Oct 15;15(8):2185-95
references.pmid: 21395369
references.citation: Clin Cancer Res. 2012 Mar 15;18(6):1751-9
references.pmid: 22275504
references.citation: J Cancer Res Clin Oncol. 2011 Feb;137(2):305-10
references.pmid: 20407789
references.citation: Biol Blood Marrow Transplant. 2005 Mar;11(3):181-7
references.pmid: 15744236
references.citation: Front Oncol. 2012 Apr 09;2:32
references.pmid: 22655268
references.citation: Science. 2006 Oct 6;314(5796):126-9
references.pmid: 16946036
references.citation: World J Gastroenterol. 2002 Jun;8(3):464-8
references.pmid: 12046071
references.citation: Oncoimmunology. 2012 Aug 1;1(5):735-738
references.pmid: 22934265
references.citation: Cancer Res. 2011 Sep 1;71(17):5601-5
references.pmid: 21846822
references.citation: Cancer Res. 1981 Nov;41(11 Pt 1):4420-5
references.pmid: 6975652
references.citation: Science. 1984 Sep 28;225(4669):1487-9
references.pmid: 6332379
references.citation: Cancer Res. 2005 Feb 1;65(3):1089-96
references.pmid: 15705911
references.citation: Blood. 2010 Nov 18;116(20):4099-102
references.pmid: 20668228
references.citation: Dig Liver Dis. 2009 Jan;41(1):36-41
references.pmid: 18818130